Russell J Benefield

443 total citations
24 papers, 133 citations indexed

About

Russell J Benefield is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Russell J Benefield has authored 24 papers receiving a total of 133 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in Russell J Benefield's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antibiotic Use and Resistance (4 papers). Russell J Benefield is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antibiotic Use and Resistance (4 papers). Russell J Benefield collaborates with scholars based in United States and South Korea. Russell J Benefield's co-authors include Peter N. Johnson, Jamie L. Miller, Jong Hun Kim, Emily S Spivak, Kimberly E. Hanson, Minkyoung Yoo, Laura Certain, Chris A. Gentry, Frank Thomas and Douglas A. Drevets and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Russell J Benefield

21 papers receiving 130 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell J Benefield United States 5 32 30 29 29 28 24 133
Roland Smonig France 7 60 1.9× 14 0.5× 51 1.8× 113 3.9× 12 0.4× 11 233
Rafael González Spain 8 22 0.7× 28 0.9× 31 1.1× 41 1.4× 15 0.5× 16 128
Sara Alcántara Carmona Spain 8 24 0.8× 4 0.1× 36 1.2× 46 1.6× 23 0.8× 28 162
Elie Kantor France 8 26 0.8× 8 0.3× 17 0.6× 27 0.9× 16 0.6× 21 131
Fantahun Tarekegn Kumie Ethiopia 6 36 1.1× 24 0.8× 12 0.4× 18 0.6× 6 0.2× 18 128
S. Paulus France 9 133 4.2× 3 0.1× 47 1.6× 101 3.5× 30 1.1× 14 226
Lan N. Bui United States 4 26 0.8× 4 0.1× 59 2.0× 14 0.5× 37 1.3× 14 117
В. В. Кулабухов Russia 7 18 0.6× 13 0.4× 27 0.9× 51 1.8× 1 0.0× 33 123
Cecilia Gómez Ravetti Brazil 7 33 1.0× 14 0.5× 60 2.1× 50 1.7× 2 0.1× 24 159
Pierre‐Auguste Petignat Switzerland 4 16 0.5× 7 0.2× 45 1.6× 147 5.1× 3 0.1× 19 198

Countries citing papers authored by Russell J Benefield

Since Specialization
Citations

This map shows the geographic impact of Russell J Benefield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell J Benefield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell J Benefield more than expected).

Fields of papers citing papers by Russell J Benefield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell J Benefield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell J Benefield. The network helps show where Russell J Benefield may publish in the future.

Co-authorship network of co-authors of Russell J Benefield

This figure shows the co-authorship network connecting the top 25 collaborators of Russell J Benefield. A scholar is included among the top collaborators of Russell J Benefield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell J Benefield. Russell J Benefield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benefield, Russell J, et al.. (2025). Platelet response following dexamethasone in obese vs nonobese patients with primary, acute immune-mediated thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 9(3). 102844–102844.
2.
Certain, Laura, et al.. (2025). Progressive centrofacial destruction due to Acanthamoeba infection from nasal rinsing. The Lancet Infectious Diseases. 25(6). e369–e369.
3.
4.
Pham, Jonathan, et al.. (2024). In vitro activity of omadacycline against clinical isolates of Nocardia. Antimicrobial Agents and Chemotherapy. 68(5). e0168623–e0168623. 3 indexed citations
5.
Benefield, Russell J, et al.. (2023). Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(9). 894–903. 2 indexed citations
6.
Benefield, Russell J, et al.. (2023). Switching from intravenous vancomycin to oral antibiotics reduces adverse events in a retrospective cohort of outpatients with orthopedic infections. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(12). 1277–1285. 2 indexed citations
7.
Benefield, Russell J, et al.. (2022). 909. Impact of Implementing an IV to PO Antibiotic Treatment Protocol for Orthopedic Infections on Prescribing Habits and Health Utilization Outcomes. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations
8.
Certain, Laura, Russell J Benefield, Michael Newman, Mingyuan Zhang, & Frank O Thomas. (2022). A Quality Initiative to Improve Postdischarge Care for Patients on Outpatient Parenteral Antimicrobial Therapy. Open Forum Infectious Diseases. 9(7). ofac199–ofac199. 3 indexed citations
9.
Benefield, Russell J, et al.. (2021). 232. Safety and Effectiveness of Intravenous to Oral De-escalation Compared to Continued Vancomycin Therapy in Orthopedic Infections. Open Forum Infectious Diseases. 8(Supplement_1). S225–S226. 1 indexed citations
10.
Timbrook, Tristan T., Polina Kukhareva, Nathan Hatton, et al.. (2020). A Pathway for Community-Acquired Pneumonia With Rapid Conversion to Oral Therapy Improves Health Care Value. Open Forum Infectious Diseases. 7(11). ofaa497–ofaa497. 11 indexed citations
11.
12.
Olson, Jared, et al.. (2019). 2109. Liposomal Amphotericin B-associated Nephrotoxicity in Obese and Non-obese Patients. Open Forum Infectious Diseases. 6(Supplement_2). S714–S714. 1 indexed citations
13.
14.
Certain, Laura, Russell J Benefield, & Frank O Thomas. (2019). 748. Does Improving Discharge Documentation Improve Post-Discharge Care for Patients on Outpatient Parenteral Antimicrobial Therapy (OPAT)?. Open Forum Infectious Diseases. 6(Supplement_2). S334–S334. 1 indexed citations
15.
Yoo, Minkyoung, et al.. (2018). Impact of a Multiplex PCR Assay for Bloodstream Infections With and Without Antimicrobial Stewardship Intervention at a Cancer Hospital. Open Forum Infectious Diseases. 5(10). ofy258–ofy258. 27 indexed citations
16.
Sierra‐Hoffman, Miguel, et al.. (2018). 569: MINOCYCLINE IV IS EFFECTIVE IN THE TREATMENT OF INFECTIONS DUE TO GRAM-NEGATIVE BACTERIA. Critical Care Medicine. 47(1). 265–265.
17.
Benefield, Russell J, et al.. (2017). Evaluation of Vancomycin Dosing in Intravenous Drug Users Admitted to an Internal Medicine Service. Open Forum Infectious Diseases. 4(suppl_1). S291–S291. 2 indexed citations
18.
Kim, Jong Hun, et al.. (2016). Utilization of posaconazole oral suspension or delayed‐released tablet salvage treatment for invasive fungal infection. Mycoses. 59(11). 726–733. 9 indexed citations
19.
Benefield, Russell J, et al.. (2015). Risk of Fungal Endophthalmitis Associated with Cataract Surgery: A Mini-Review. Mycopathologia. 180(5-6). 291–297. 12 indexed citations
20.
Benefield, Russell J, Douglas A. Drevets, Mark M. Huycke, & Chris A. Gentry. (2012). A Multicenter Evaluation of the Safety of Drotrecogin Alfa (Activated) in Patients with Baseline Bleeding Precautions. Current Drug Safety. 7(1). 3–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roland Smonig Breakdown of academic impact, for papers by Rafael González Breakdown of academic impact, for papers by Sara Alcántara Carmona Breakdown of academic impact, for papers by Elie Kantor Breakdown of academic impact, for papers by Fantahun Tarekegn Kumie Breakdown of academic impact, for papers by S. Paulus Breakdown of academic impact, for papers by Lan N. Bui Breakdown of academic impact, for papers by В. В. Кулабухов Breakdown of academic impact, for papers by Cecilia Gómez Ravetti Breakdown of academic impact, for papers by Pierre‐Auguste Petignat
Rankless by CCL
2026